| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |